
The White House won’t meet an expected Wednesday deadline to nominate a new director of the Centers for Disease Control and Prevention. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Dr. Jay Bhattacharya had been acting director of the CDC, but that title will expire Thursday under federal law, which says the government can have an acting director position for only a set period.
Main Idea: The Trump administration is delaying a new CDC director pick, leaving Dr. Jay Bhattacharya to oversee the agency for now while staff worry about weak leadership and falling trust.
Key Points:
Delays in naming a CDC chief can slow outbreak response, funding, and health guidance, which may leave patients and communities with less clear protection.
A stronger, science-focused leader could restore trust and help the CDC work better for families, workers, and taxpayers.
Rate how each entity in this article affected the American people.
Central CDC acting director whose role, comments, and status in the nomination delay drive the story.
The agency at the center of the leadership vacancy, staff concerns, and policy direction.
His administration is expected to name the next CDC head, making him a central decision-maker in the article.
Health secretary whose views and influence over CDC leadership and vaccine policy are a major focus.
Former CDC director whose firing and testimony are key parts of the leadership turmoil described.
Named as a potential CDC nominee on the reported short list.
Public health official quoted assessing what kind of CDC leader is needed; supportive context.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentFormer CDC official quoted describing the agency’s leadership vacuum and lack of priorities.
Former CDC director mentioned as another potential nominee and tied to measles vaccination remarks.
Mentioned through David Margolius’s affiliation as background for his perspective.